PAVmed (PAVM) Equity Ratio (2021 - 2025)
PAVmed (PAVM) has 5 years of Equity Ratio data on record, last reported at 0.85 in Q3 2025.
- For Q3 2025, Equity Ratio changed N/A year-over-year to 0.85; the TTM value through Sep 2025 reached 0.85, changed N/A, while the annual FY2024 figure was 0.08, 88.78% up from the prior year.
- Equity Ratio reached 0.85 in Q3 2025 per PAVM's latest filing, up from 0.64 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.94 in Q1 2021 and bottomed at 0.73 in Q4 2023.
- Average Equity Ratio over 5 years is 0.31, with a median of 0.39 recorded in 2022.
- Peak YoY movement for Equity Ratio: tumbled 2959.23% in 2024, then soared 235.63% in 2025.
- A 5-year view of Equity Ratio shows it stood at 0.91 in 2021, then plummeted by 77.82% to 0.2 in 2022, then plummeted by 458.03% to 0.73 in 2023, then skyrocketed by 88.78% to 0.08 in 2024, then skyrocketed by 1149.74% to 0.85 in 2025.
- Per Business Quant database, its latest 3 readings for Equity Ratio were 0.85 in Q3 2025, 0.64 in Q2 2025, and 0.74 in Q1 2025.